303 related articles for article (PubMed ID: 17307877)
1. Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization.
García-Alvarez B; de Cárcer G; Ibañez S; Bragado-Nilsson E; Montoya G
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3107-12. PubMed ID: 17307877
[TBL] [Abstract][Full Text] [Related]
2. Polo-box domains confer target specificity to the Polo-like kinase family.
van de Weerdt BC; Littler DR; Klompmaker R; Huseinovic A; Fish A; Perrakis A; Medema RH
Biochim Biophys Acta; 2008 Jun; 1783(6):1015-22. PubMed ID: 18359294
[TBL] [Abstract][Full Text] [Related]
3. Crystallization and preliminary X-ray diffraction studies on the human Plk1 Polo-box domain in complex with an unphosphorylated and a phosphorylated target peptide from Cdc25C.
García-Alvarez B; Ibañez S; Montoya G
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Apr; 62(Pt 4):372-5. PubMed ID: 16582488
[TBL] [Abstract][Full Text] [Related]
4. Different Plk1 functions show distinct dependencies on Polo-Box domain-mediated targeting.
Hanisch A; Wehner A; Nigg EA; Silljé HH
Mol Biol Cell; 2006 Jan; 17(1):448-59. PubMed ID: 16267267
[TBL] [Abstract][Full Text] [Related]
5. A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1.
Reindl W; Strebhardt K; Berg T
Anal Biochem; 2008 Dec; 383(2):205-9. PubMed ID: 18793607
[TBL] [Abstract][Full Text] [Related]
6. Plk1 activation by Ste20-like kinase (Slk) phosphorylation and polo-box phosphopeptide binding assayed with the substrate translationally controlled tumor protein (TCTP).
Johnson TM; Antrobus R; Johnson LN
Biochemistry; 2008 Mar; 47(12):3688-96. PubMed ID: 18298087
[TBL] [Abstract][Full Text] [Related]
7. Polo-like kinase 1 regulates mitotic arrest after UV irradiation through dephosphorylation of p53 and inducing p53 degradation.
Chen J; Dai G; Wang YQ; Wang S; Pan FY; Xue B; Zhao DH; Li CJ
FEBS Lett; 2006 Jun; 580(15):3624-30. PubMed ID: 16753148
[TBL] [Abstract][Full Text] [Related]
8. Targeting subcellular localization through the polo-box domain: non-ATP competitive inhibitors recapitulate a PLK1 phenotype.
McInnes C; Estes K; Baxter M; Yang Z; Farag DB; Johnston P; Lazo JS; Wang J; Wyatt MD
Mol Cancer Ther; 2012 Aug; 11(8):1683-92. PubMed ID: 22848093
[TBL] [Abstract][Full Text] [Related]
9. Rational Molecular Design of Potent PLK1 PBD Domain-binding Phosphopeptides Using Preferential Amino Acid Building Blocks.
Mao XL; Wang KF; Zhu F; Pan ZH; Wu GM; Zhu HY
Chem Biodivers; 2016 Aug; 13(8):1103-10. PubMed ID: 27450535
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1.
Yun SM; Moulaei T; Lim D; Bang JK; Park JE; Shenoy SR; Liu F; Kang YH; Liao C; Soung NK; Lee S; Yoon DY; Lim Y; Lee DH; Otaka A; Appella E; McMahon JB; Nicklaus MC; Burke TR; Yaffe MB; Wlodawer A; Lee KS
Nat Struct Mol Biol; 2009 Aug; 16(8):876-82. PubMed ID: 19597481
[TBL] [Abstract][Full Text] [Related]
11. Cancer Osaka thyroid (Cot) phosphorylates Polo-like kinase (PLK1) at Ser137 but not at Thr210.
Wu B; Jiang P; Mu Y; Wilmouth RC
Biol Chem; 2009 Dec; 390(12):1271-7. PubMed ID: 19804365
[TBL] [Abstract][Full Text] [Related]
12. Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates.
Elia AE; Cantley LC; Yaffe MB
Science; 2003 Feb; 299(5610):1228-31. PubMed ID: 12595692
[TBL] [Abstract][Full Text] [Related]
13. Structure and function of Polo-like kinases.
Lowery DM; Lim D; Yaffe MB
Oncogene; 2005 Jan; 24(2):248-59. PubMed ID: 15640840
[TBL] [Abstract][Full Text] [Related]
14. Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1.
Neef R; Gruneberg U; Kopajtich R; Li X; Nigg EA; Sillje H; Barr FA
Nat Cell Biol; 2007 Apr; 9(4):436-44. PubMed ID: 17351640
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential Plk1 targets in a cell-cycle specific proteome through structural dynamics of kinase and Polo box-mediated interactions.
Bibi N; Parveen Z; Rashid S
PLoS One; 2013; 8(8):e70843. PubMed ID: 23967120
[TBL] [Abstract][Full Text] [Related]
16. Sequential phosphorylation of Nedd1 by Cdk1 and Plk1 is required for targeting of the gammaTuRC to the centrosome.
Zhang X; Chen Q; Feng J; Hou J; Yang F; Liu J; Jiang Q; Zhang C
J Cell Sci; 2009 Jul; 122(Pt 13):2240-51. PubMed ID: 19509060
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of the polo-box domain of human Polo-like kinase 2.
Kim JH; Ku B; Lee KS; Kim SJ
Proteins; 2015 Jul; 83(7):1201-8. PubMed ID: 25846005
[TBL] [Abstract][Full Text] [Related]
18. Computational analysis of phosphopeptide binding to the polo-box domain of the mitotic kinase PLK1 using molecular dynamics simulation.
Huggins DJ; McKenzie GJ; Robinson DD; Narváez AJ; Hardwick B; Roberts-Thomson M; Venkitaraman AR; Grant GH; Payne MC
PLoS Comput Biol; 2010 Aug; 6(8):. PubMed ID: 20711360
[TBL] [Abstract][Full Text] [Related]
19. A new class of peptidomimetics targeting the polo-box domain of Polo-like kinase 1.
Ahn M; Han YH; Park JE; Kim S; Lee WC; Lee SJ; Gunasekaran P; Cheong C; Shin SY; Kim HY; Ryu EK; Murugan RN; Kim NH; Bang JK
J Med Chem; 2015 Jan; 58(1):294-304. PubMed ID: 25347203
[TBL] [Abstract][Full Text] [Related]
20. Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner.
Astrinidis A; Senapedis W; Henske EP
Hum Mol Genet; 2006 Jan; 15(2):287-97. PubMed ID: 16339216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]